Verapamil regulates activity and mRNA-expression of human β-glucuronidase in HepG2 cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 368, Issue 6, 2003, Pages 463-469

  Grube, M ^a   Kunert Keil, C ^a   Sperker, B ^a   Kroemer, H K ^a  

^a Research Center of Pharmacology and Experimental Therapeutics   (Germany)

Author keywords

glucuronidase; HepG2; Regulation; Verapamil

Indexed keywords

BETA GLUCURONIDASE; MESSENGER RNA; PRODRUG; VERAPAMIL;

ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CYTOSTASIS; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GENES, REPORTER; GLUCURONIDASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; HYMECROMONE; LIVER NEOPLASMS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; STEREOISOMERISM; TIME FACTORS; TRANSFECTION; VERAPAMIL;

EID: 0346731049     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0837-x     Document Type: Article

References (36)

1. Akiyama Y (1995) TFSEARCH: searching transcription factor binding sites. http://www.rwcp.or.jp/papia/
2. Bosslet K, Czech J, Hoffmann D (1994) Tumor-selective prodrug activation by fusionprotein-mediated catalysis. Cancer Res 54: 2151-2159
3. Caldwell JH, Greenberger NJ (1971) Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. J Clin Invest 50:2626-2637
4. Corrales-Hernandez JJ, Gonzalez-Buitrago JM, Pastor-Encinas I, Garcia-Diez LC, Miralles JM (1988) Androgen environment and beta-glucuronidase activity in the human kidney. Arch Androl 20:185-191
5. Echizen H, Manz M, Eichelbaum M (1988) Electrophysiologic effects of dextro- and levo-verapamil on sinus node and AV node function in humans. J Cardiovasc Pharmacol 12:543-546
6. Fishman WH, Kato K, Anstiss CL, Green S (1967) Human serum beta-glucuronidase; its measurement and some of its properties. Clin Chim Acta 15:435-447
7. Gehrmann MC, Opper M, Sedlacek HH, Bosslet K, Czech J (1994) Biochemical properties of recombinant human beta-glucuronidase synthesized in baby hamster kidney cells. Biochem J 301:821-828
8. Gupta GS, Singh G (1983) Immunological specificity of beta-glucuronidase from human seminal plasma and its immunolocalization in the human reproductive tract. Am J Reprod Immunol 4:122-126
9. Harlow E (1988) Immunoblotting protocols. In: Antibodies. A Laboratory Manual pp 479-510. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
10. Heinert G, Scherberich J, Mondorf W, Weber W (1983) Quantitative enzymatic and immunologic computer-assisted histophotometry of human kidney tissue following neoplastic and other clinically significant alterations. Eur Urol 9:235-241
11. Herman RJ, Van Pham JD, Szakacs CB (1989) Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect. Clin Pharmacol Ther 46:18-25
12. Isidoro C, Baccino FM, Hasilik A (1997) Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal. Int J Cancer 70:561-566
13. Islam MR, Grubb JH, Sly WS (1993) C-terminal processing of human beta-glucuronidase. The propeptide is required for full expression of catalytic activity, intracellular retention, and proper phosphorylation. J Biol Chem 268:22627-22633
14. Jain S, Drendel WB, Chen ZW, Mathews FS, Sly WS, Grubb JH (1996) Structure of human beta-glucuronidase reveals candidate lysosomal targeting and active-site motifs. Nat Struct Biol 3:375-381
15. Kunert-Keil C, Bien S, Siegele I, Mürdter TE, Fritz P, Siegmund W, Kroemer HK, Sperker B (2001) Induction of human beta-glucuronidase expression by rifampicin. Biol Chem 382:105
16. Lotsch J, Sperker B, Kroemer HK, Geisslinger G (2002) Verapamil decreases glucuronidase activity in the gut. Biochem Pharmacol 63:1575-1578
17. Mikus G, Eichelbaum M, Fischer C, Gumulka S, Klotz U, Kroemer HK (1990) Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. J Pharmacol Exp Ther 253:1042-1048
18. Miller RD, Hoffmann JW, Powell PP, Kyle JW, Shipley JM, Bachinsky DR, Sly WS (1990) Cloning and characterization of the human beta-glucuronidase gene. Genomics 7:280-283
19. Murdter TE, Sperker B, Kivisto KT, McClellan M, Fritz P, Friedel G, Linder A, Bosslet K, Toomes H, Dierkesmann R, Kroemer HK (1997) Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Cancer Res 57:2440-2445
20. Murdter TE, Friedel G, Backman JT, McClellan M, Schick M, Gerken M, Bosslet K, Fritz P, Toomes H, Kroemer HK, Sperker B (2002) Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase. J Pharmacol Exp Ther 301:223-228
21. Oshima A, Kyle JW, Miller RD, Hoffmann JW, Powell PP, Grubb JH, Sly WS, Tropak M, Guise KS, Gravel RA (1987) Cloning, sequencing, and expression of cDNA for human beta-glucuronidase. Proc Natl Acad Sci USA 84:685-689
22. Paigen K (1989) Mammalian beta-glucuronidase: genetics, molecular biology, and cell biology. Prog Nucleic Acid Res Mol Biol 37:155-205
23. Platt D (1970) Biochemischer und histochemischer Nachweis der b-Glukuronidase und b-Azetylglukosaminidase in normalen und pathologisch veränderten Lymphknoten. Blut 284:1-6
24. Rollins DE, Klaassen CD (1979) Biliary excretion of drugs in man. Clin Pharmacokinet 4:368-379
25. Shipley JM, Miller RD, Wu BM, Grubb JH, Christensen SG, Kyle JW, Sly WS (1991) Analysis of the 5′ flanking region of the human beta-glucuronidase gene. Genomics 10:1009-1018
26. Sly WS, Quinton BA, McAlister WH, Rimoin DL (1973) Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 82:249-257
27. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85
28. Sperker B, Schick M, Kroemer HK (1996) High-performance liquid chromatographic quantification of 4-methylumbelliferyl-beta-D-glucuronide as a probe for human beta-glucuronidase activity in tissue homogenates. J Chromatogr B Biomed Appl 685:181-184
29. Sperker B, Backman JT, Kroemer HK (1997a) The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33:18-31
30. Sperker B, Murdter TE, Schick M, Eckhardt K, Bosslet K, Kroemer HK (1997b) Interindividual variability in expression and activity of human beta-glucuronidase in liver and kidney: consequences for drug metabolism. J Pharmacol Exp Ther 281: 914-920
31. Sperker B, Werner U, Murdter TE, Tekkaya C, Fritz P, Wacke R, Adam U, Gerken M, Drewelow B, Kroemer HK (2000) Expression and function of beta-glucuronidase in pancreatic cancer: potential role in drug targeting. Naunyn-Schmiedebergs Arch Pharmacol 362:110-115
32. Sperker B, Tomkiewicz C, Burk O, Barouki R, Kroemer HK (2001) Regulation of human beta-glucuronidase by A23187 and thapsigargin in the hepatoma cell line HepG2. Mol Pharmacol 59:177-182
33. Tanaka J, Gasa S, Sakurada K, Miyazaki T, Kasai M, Makita A (1992) Characterization of the subunits and sugar moiety of human placental and leukemic beta-glucuronidase. Biol Chem Hoppe Seyler 373:57-62
34. Von Richter O, Greiner B, Fromm MF, Fraser R, Omari T, Barclay ML, Dent J, Somogyi AA, Eichelbaum M (2001) Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique. Clin Pharmacol Ther 70:217-227
35. Zenser TV, Lakshmi VM, Davis BB (1999) Human and Escherichia coli beta-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl, and their hydroxy metabolites. Drug Metab Dispos 27:1064-1067
36. Zhu Y, Conner GE (1994) Intermolecular association of lysosomal protein precursors during biosynthesis. J Biol Chem 269:3846-3851